✦ LIBER ✦

Hormone replacement therapy and lobular breast carcinoma

✍ Scribed by Roger N. Maric; Kar K. Cheng

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 49 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20001015)89:8<1867::aid-cncr31>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone replacement therapy in relation

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

✍ Christopher I. Li; Noel S. Weiss; Janet L. Stanford; Janet R. Daling 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Relation of regimens of combined hormone

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

✍ Janet R. Daling; Kathleen E. Malone; David R. Doody; Lynda F. Voigt; Leslie Bern 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Background: The incidence of invasive lobular carcinoma has been increasing among postmenopausal women in some parts of the united states. part of this may be due to changes in classification over time. however, the use of combined (estrogen and progestin) hormone replacement therapy (chrt) also

Are older breast carcinoma survivors wil

Are older breast carcinoma survivors willing to take hormone replacement therapy?

✍ Patricia A. Ganz; Gail A. Greendale; Barbara Kahn; June F. O'Leary; Katherine A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## BACKGROUND. Breast carcinoma survivors are the largest segment of the expanding cancer survivor community. As a result, there has been increasing discussion of the safety and efficacy of hormone replacement therapy for women with a past history of breast carcinoma. Little is known about the will

Hormone replacement therapy and breast c

Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women

✍ Rui Li; Frank D. Gilliland; Kathy Baumgartner; Jonathan Samet 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Background: Hormone replacement therapy (hrt) alleviates menopausal symptoms and prevents osteoporosis, but there is concern that long-term use may have an adverse impact on breast carcinoma risk. epidemiologic studies report inconsistent findings regarding the relationship between hrt and postm

Hormone replacement therapy containing p

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden

✍ Nirav R. Shah 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

## Hormone Replacement Therapy Containing Progestins and Given Continuously Increases Breast Carcinoma Risk in Sweden I read with interest the article by Olsson et al. 1 reporting their experience with a large Swedish cohort in which hormone replacement therapy and the risk of breast carcinoma wer

Hormone replacement therapy containing p

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden

✍ Håkan L. Olsson; Christian Ingvar; Anna Bladström 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Background: The authors previously reported an increased risk of breast carcinoma with longer duration of hormone replacement therapy (hrt) use. it is unclear if different types of hrt confer different risks. ## Methods: In this study, a population-based cohort of 29,508 women were interviewed